Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 8
2012 5
2013 7
2014 4
2015 6
2016 8
2017 6
2018 5
2019 8
2020 5
2021 5
2022 8
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
A Machine Learning Algorithm Facilitates Prognosis Prediction and Treatment Selection for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma.
Han JW, Lee SK, Kwon JH, Nam SW, Yang H, Bae SH, Kim JH, Nam H, Kim CW, Lee HL, Kim HY, Lee SW, Lee A, Chang UI, Song DS, Kim SH, Song MJ, Sung PS, Choi JY, Yoon SK, Jang JW. Han JW, et al. Among authors: song mj. Clin Cancer Res. 2024 Apr 19. doi: 10.1158/1078-0432.CCR-23-3978. Online ahead of print. Clin Cancer Res. 2024. PMID: 38639918
Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative study.
Han JW, Sung PS, Yoo JS, Cho HS, Lee SK, Yang H, Kim JH, Nam H, Lee HL, Kim HY, Lee SW, Song DS, Song MJ, Kwon JH, Kim CW, Bae SH, Jang JW, Choi JY, Yoon SK. Han JW, et al. Among authors: song mj. Front Oncol. 2024 Feb 28;14:1372007. doi: 10.3389/fonc.2024.1372007. eCollection 2024. Front Oncol. 2024. PMID: 38482199 Free PMC article.
A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis.
Lee SK, Kwon JH, Lee SW, Lee HL, Kim HY, Kim CW, Song DS, Chang UI, Yang JM, Nam SW, Kim SH, Song MJ, Kim JH, Lee A, Yang H, Bae SH, Han JW, Nam H, Sung PS, Jang JW, Choi JY, Yoon SK, Shim DJ, Kim D, Kim M. Lee SK, et al. Among authors: song mj. Cancers (Basel). 2023 Sep 4;15(17):4423. doi: 10.3390/cancers15174423. Cancers (Basel). 2023. PMID: 37686699 Free PMC article.
A global research priority agenda to advance public health responses to fatty liver disease.
Lazarus JV, Mark HE, Allen AM, Arab JP, Carrieri P, Noureddin M, Alazawi W, Alkhouri N, Alqahtani SA, Arrese M, Bataller R, Berg T, Brennan PN, Burra P, Castro-Narro GE, Cortez-Pinto H, Cusi K, Dedes N, Duseja A, Francque SM, Hagström H, Huang TT, Wajcman DI, Kautz A, Kopka CJ, Krag A, Miller V, Newsome PN, Rinella ME, Romero D, Sarin SK, Silva M, Spearman CW, Tsochatzis EA, Valenti L, Villota-Rivas M, Zelber-Sagi S, Schattenberg JM, Wong VW, Younossi ZM; Healthy Livers, Healthy Lives Collaborators. Lazarus JV, et al. J Hepatol. 2023 Sep;79(3):618-634. doi: 10.1016/j.jhep.2023.04.035. Epub 2023 Jun 20. J Hepatol. 2023. PMID: 37353401 Free article.
Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease.
Ryu JE, Song MJ, Kim SH, Kwon JH, Yoo SH, Nam SW, Nam HC, Kim HY, Kim CW, Yang H, Bae SH, Song DS, Chang UI, Yang JM, Lee SW, Lee HL, Lee SK, Sung PS, Jang JW, Choi JY, Yoon SK. Ryu JE, et al. Among authors: song mj. Korean J Intern Med. 2022 Sep;37(5):958-968. doi: 10.3904/kjim.2021.486. Epub 2022 Aug 19. Korean J Intern Med. 2022. PMID: 35981893 Free PMC article.
76 results